TFIIB Antibodies

Santa Cruz Biotechnology features a diverse variety of TFIIB monoclonal antibodies for research in transcription regulation and gene expression. TFIIB monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFIIB, or Transcription Factor IIB, plays a crucial role in the initiation of transcription by RNA polymerase II, serving as a bridge between the transcription machinery and the promoter region of genes. Its function is essential for the accurate and efficient transcription of protein-coding genes, making TFIIB a key player in cellular processes such as growth, differentiation, and response to environmental signals. Understanding the dynamics of TFIIB is vital for elucidating the mechanisms of gene regulation and the implications of transcriptional dysregulation in various diseases. Researchers can explore the complex interactions between TFIIB and other transcription factors to better understand gene expression control mechanisms. Advanced visualization techniques using TFIIB monoclonal antibodies enable detailed analysis of protein localization and dynamics within cellular compartments. Investigating TFIIB's role in different cell types provides valuable information about tissue-specific gene regulation patterns. Santa Cruz Biotechnology monoclonal antibodies for TFIIB support researchers worldwide in advancing our understanding of transcriptional regulation and its impact on human health.